Oral fluid and hepatitis A, B and C: A literature review

Journal of Oral Pathology and Medicine

Volumn 41, Issue 7, 2012, Pages 505-516

  Mahboobi, Nima ^a   Porter, Stephen R ^b   Karayiannis, Peter ^c   Alavian, Seyed Moayed ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Baqiyatallah Medical Sciences University Baqyatallah Hospital   (Iran)

Author keywords

Gingival crevicular fluid; Health precaution; Hepatitis A; Hepatitis B; Hepatitis C; Literature review; Oral fluid; Saliva

Indexed keywords

INTERFERON; RIBAVIRIN;

ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; GINGIVITIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; SALIVA; VIRUS TRANSMISSION;

GINGIVAL CREVICULAR FLUID; HEPACIVIRUS; HEPATITIS A VIRUS, HUMAN; HEPATITIS B VIRUS; HEPATITIS, VIRAL, HUMAN; HUMANS; SALIVA; VIRAL LOAD;

EID: 84864381940     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01123.x     Document Type: Article

References (107)

1. Keystone JS, Hershey JH. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule. Int J Infect Dis 2008; 12: 3-11.
2. Gillcrist J. Hepatitis viruses A, B, C, D, E and G-implications for dental personnel. J Am Dent Assoc 1999; 130: 509-20.
3. Nasir A TC, Stanekzai MR, Bautista CT, et al. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy 2011; 22: 145-52.
4. Azarkar Z, Sharifzadeh G. Evaluation of the prevalence of hepatitis B, hepatitis C, and HIV in inmates with drug-related convictions in Birjand, Iran in 2008. Hepat Mon 2010; 10: 26-30.
5. O'Connell T, Thornton L, O'Flanagan D, et al. Oral fluid collection by post for viral antibody testing. Int J Epidemiol 2001; 30: 298-301.
6. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology 2010; 53: 15-9.
7. Wasley A, Fiore A, Bell B. Hepatitis A in the era of vaccination. Epidemiol Rev 2006; 28: 101-11.
8. Dentinger C. Hepatitis A: an update. Am J Nurs 2009; 109: 29-33.
9. Mahboobi N, Safari S, Alavian S. Hepatitis A virus in Middle East countries: more evidence needed. Arab J Gastroenterol 2010; 11: 1-2.
10. Koslap-Petraco MB, Shub M, Judelsohn R. Hepatitis A: disease burden and current childhood vaccination strategies in the United States. J Pediatr Health Care 2008; 22: 3-11.
11. Oba IT, Spina AM, Saraceni CP, et al. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. Rev Inst Med Trop Sao Paulo 2000; 42: 197-200.
12. Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R. Autoimmune hepatitis induced by the prolonged hepatitis A virus infection. Ann Hepatol 2008; 7: 177-9.
13. Chitambar SD, Fadnis RS, Joshi MS, Habbu A, Bhatia SG. Case report: hepatitis A preceding Guillain-Barre syndrome. J Med Virol 2006; 78: 1011-4.
14. Fan PC, Chen YC, Tian YC, Chang CH, Fang JT, Yang CW. Acute renal failure associated with acute non-fulminant hepatitis A: a case report and review of literature. Ren Fail 2009; 31: 756-64.
15. Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol 2007; 13: 2238-9.
16. Karali Z, Basaranoglu ST, Karali Y, Oral B, Kilic SS. Autoimmunity and hepatitis A vaccine in children. J Investig Allergol Clin Immunol 2011; 21: 389-93.
17. Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc 2006; 117: 227-38.
18. Mackiewicz V, Dussaix E, Le Petitcorps MF, Roque-Afonso AM. Detection of hepatitis A virus RNA in saliva. J Clin Microbiol 2004; 42: 4329-31.
19. Amado LA, Villar LM, de Paula VS, Gaspar AM. Comparison between serum and saliva for the detection of hepatitis A virus RNA. J Virol Methods 2008; 148: 74-80.
20. Ahmed M MS, Andalib S, Tabassum S, Islam MN. Testing hepatitis A virus antibody in oral fluid among the prospective vaccinees foster the need of new oral HAV rapid test. Indian J Med Microbiol 2011; 29: 72-3.
21. Tourinho RS AL, Villar LM, Sampaio DV, et al. Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay. J Virol Methods 2011; 173: 169-74. In press.
22. Morris-Cunnington MC, Edmunds WJ, Miller E, Brown DW. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 2004; 159: 786-94.
23. Matheson K, Halperin B, McNeil S, Langley JM, MacKinnon-Cameron D, Sa H. Hepatitis A and travel amongst Nova Scotia postsecondary students: Evidence for a targeted vs. universal immunization strategy. Vaccine 2010; 28: 8105-11.
24. Rizzetto M, Ciancio A. Chronic HBV-related liver disease. Mol Aspects Med 2008; 29: 72-84.
25. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int 2009; 29: 1-8.
26. Dehesa-Violante M, Nunez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007; 38: 606-11.
27. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14: 1-21.
28. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008; 13: 18880.
29. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61: 362-6.
30. Alavian SM, Hajarizadeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B virus infection in Iran: a systematic review. Hepat Mon 2008; 8: 281-94.
31. Sinn DH, Paik SW, Kang P, et al. Disease progression and the risk factor analysis for chronic hepatitis C. Liver Int 2008; 28: 1363-9.
32. Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 2009; 124: 690-7.
33. Foster GR. Recent advances in viral hepatitis. Clin Med 2009; 9: 613-6.
34. Mallet V, Vallet-Pichard A, Pol S. The impact of human immunodeficiency virus on viral hepatitis. Liver Int 2011; 31: 135-9.
35. Chacko EC, Surrun SK, Mubarack Sani TP, Pappachan JM. Chronic viral hepatitis and chronic kidney disease. Postgrad Med J 2010; 86: 486-92.
36. Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009; 115: 5651-61.
37. Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 2008; 34: 85-102.
38. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009; 49: S13-21.
39. Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev 2007; 20: 426-39.
40. Alavi S, Behdad F. Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006). Hepat Mon 2010; 10: 101-4.
41. Lee SA, Yoo SY, Kay KS, Kook JK. Detection of hepatitis B virus and Mycobacterium tuberculosis in Korean dental patients. J Microbiol 2004; 42: 239-42.
42. Mahboobi N, Agha-Hosseini F, Mahboobi N, Safari S, Lavanchy D, Alavian SM. Hepatitis B virus infection in dentistry: a forgotten topic. J Viral Hepat 2010; 17: 307-16.
43. Heiberg IL, Hoegh M, Ladelund S, Niesters HG, Hogh B. Hepatitis B virus DNA in saliva from children with chronic hepatitis B infection: implications for saliva as a potential mode of horizontal transmission. Pediatr Infect Dis J 2010; 29: 465-7.
44. Nokes DJ, Enquselassie F, Nigatu W, et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 2001; 79: 588-95.
45. Fisker N, Georgsen J, Stolborg T, Khalil MR, Christensen PB. Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centres. J Med Virol 2002; 68: 500-4.
46. Hutse V, Verhaegen E, De Cock L, et al. Oral fluid as a medium for the detection of hepatitis B surface antigen. J Med Virol 2005; 77: 53-6.
47. Cruz HM, da Silva EF, Villela-Nogueira CA, et al. Evaluation of saliva specimens as an alternative sampling method to detect hepatitis B surface antigen. J Clin Lab Anal 2011; 25: 134-41.
48. van der Eijk AA, Niesters HG, Gotz HM, et al. Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J Clin Virol 2004; 29: 92-4.
49. Noppornpanth S, Sathirapongsasuti N, Chongsrisawat V, Poovorawan Y. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers. Southeast Asian J Trop Med Public Health 2000; 31: 419-21.
50. Kidd-Ljunggren K, Holmberg A, Blackberg J, Lindqvist B. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 2006; 64: 352-7.
51. Chen L, Liu F, Fan X, et al. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int J Infect Dis 2009; 13: 20-3.
52. van der Eijk AA, Niesters HG, Hansen BE, et al. Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients. Eur J Gastroenterol Hepatol 2005; 17: 1173-9.
53. Meo SA, Assad AA, Sanie FM, Baksh ND, Al-Qahtani A, Shaikh ZA. Transmission of hepatitis-B virus through salivary blood group antigens in saliva. J Coll Physicians Surg Pak 2010; 20: 444-8.
54. Zhevachevsky NG, Nomokonova NY, Beklemishev AB, Belov GF. Dynamic study of HBsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance. J Med Virol 2000; 61: 433-8.
55. Hui AY, Hung LC, Tse PC, Leung WK, Chan PK, Chan HL. Transmission of hepatitis B by human bite - confirmation by detection of virus in saliva and full genome sequencing. J Clin Virol 2005; 33: 254-6.
56. Butler LM, Neilands TB, Mosam A, Mzolo S, Martin JN. A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children. Trop Med Int Health 2010; 15: 442-53.
57. Lodi G, Porter SR, Scully C. Hepatitis C virus infection - review and implications for the dentist. oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 8-22.
58. Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29: 74-81.
59. Saadoun D, Terrier B, Semoun O, Sene D, et al. Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res (Hoboken) 2010; In press.
60. Morcos NY, Hassanein MH, Eliase NY, Bayoumi Eel-D, Mustafa IM. Chronic hepatitis C virus infection: prevalence of cryoglobulinemia and renal affection in the Egyptian patients. J Egypt Soc Parasitol 2010; 40: 539-50.
61. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011; 117: 1792-8.
62. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17: 1730-3.
63. Rustgi VK. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007; 42: 513-21.
64. Alavian SM, Ahmadzad Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009; 9: 211-23.
65. Amini S, Farahani Majd Abadi M, Alavian SM, Joulaie M, Ahmadipour MH. Distribution of hepatitis C virus genotypes in Iran: a population-based study. Hepat Mon 2009; 9: 95-102.
66. Dionne-Odom J, Osborn MK, Radziewicz H, Grakoui A, Workowski K. Acute hepatitis C and HIV coinfection. Lancet Infect Dis 2009; 9: 775-83.
67. Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol 2009; 83: 7366-74.
68. Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol 2008; 48: 353-67.
69. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008; 23: 512-20.
70. Vassilopoulos D, Calabrese LH. Extrahepatic immunological complications of hepatitis C virus infection. AIDS 2005; 19: S123-7.
71. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 2005; 17: 447-55.
72. Ferri C, Antonelli A, Mascia MT, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39: S13-21.
73. Kotler DP. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions. Liver Int 2009; 29: 38-46.
74. Alavian SM, Behnava B, Tabatabaei SV. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. Eur J Clin Pharmacol 2010; 66: 1071-9.
75. Rey D, Fritsch S, Schmitt C, Meyer P, Lang JM, Stoll-Keller F. Quantitation of hepatitis C virus RNA in saliva and serum of patients coinfected with HCV and human immunodeficiency virus. J Med Virol 2001; 63: 117-9.
76. Januszkiewicz-Lewandowska D, Wysocki J, Rembowska J, et al. Transmission of HCV infection among long-term hospitalized onco-haematological patients. J Hosp Infect 2003; 53: 120-3.
77. Ferreiro MC, Dios PD, Scully C. Transmission of hepatitis C virus by saliva? Oral Dis 2005; 11: 230-5.
78. Maticic M, Poljak M, Kramar B, et al. Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva. J Periodontol 2001; 72: 11-6.
79. van Doornum GJ, Lodder A, Buimer M, van Ameijden EJ, Bruisten S. Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum. J Med Virol 2001; 64: 13-20.
80. Judd A, Parry J, Hickman M, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003; 71: 49-55.
81. Cock De L, Hutse V, Vranckx R. Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum. Eur J Clin Microbiol Infect Dis 2005; 24: 566-8.
82. Goncalves PL, Cunha CB, Busek SC, Oliveira GC, Ribeiro-Rodrigues R, Pereira FE. Detection of hepatitis C virus RNA in saliva samples from patients with seric anti-HCV antibodies. Braz J Infect Dis 2005; 9: 28-34.
83. Lins L, Almeida H, Vitvisk L, Carmo T, Parana R, Reis MG. Detection of hepatitis C virus RNA in saliva is not related to oral health status or viral load. J Med Virol 2005; 77: 216-20.
84. Yaari A, Tovbin D, Zlotnick M, et al. Detection of HCV salivary antibodies by a simple and rapid test. J Virol Methods 2006; 133: 1-5.
85. Amado LA, Villar LM, de Paula VS, de Almeida AJ, Gaspar AM. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem Inst Oswaldo Cruz 2006; 101: 149-55.
86. Gonzalez V, Martro E, Folch C, et al. Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. Eur J Clin Microbiol Infect Dis 2008; 27: 121-6.
87. Moorthy M, Daniel HD, Kurian G, Abraham P. An evaluation of saliva as an alternative to plasma for the detection of hepatitis C virus antibodies. Indian J Med Microbiol 2008; 26: 327-32.
88. Lee SR, Yearwood GD, Guillon GB, et al. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J Clin Virol 2010; 48: 15-7.
89. Lee SR, Kardos KW, Schiff E, et al. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J Virol Methods 2011; 172: 27-31.
90. Arrieta JJ, Rodriguez-Inigo E, Ortiz-Movilla N, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001; 158: 259-64.
91. Ferreiro MC, Prieto MH, Rodriguez SB, Vazquez RL, Iglesias AC, Dios PD. Whole stimulated salivary flow in patients with chronic hepatitis C virus infection. J Oral Pathol Med 2002; 31: 117-20.
92. de Mattos Camargo Grossmann S, Teixeira R, de Oliveira GC, do Carmo MA. Detection of HCV RNA in saliva does not correlate with salivary flow or xerostomia in patients with chronic hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 851-6.
93. Grossmann Sde M, Teixeira R, Oliveira GC, et al. Xerostomia, hyposalivation and sialadenitis in patients with chronic hepatitis C are not associated with the detection of HCV RNA in saliva or salivary glands. J Clin Pathol 2010; 63: 1002-7.
94. Pastore L, Fiore JR, Tateo M, et al. Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients. Int J Immunopathol Pharmacol 2006; 19: 217-24.
95. Hermida M, Ferreiro MC, Barral S, Laredo R, Castro A, Diz Dios P. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test. J Virol Methods 2002; 101: 29-35.
96. Suzuki T, Omata K, Satoh T, et al. Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients. J Clin Microbiol 2005; 43: 4413-7.
97. Diz Dios P, Castro A, Rodriguez I, et al. HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy. J Oral Pathol Med 2005; 34: 308-11.
98. Raggam RB, Wagner J, Michelin BD, et al. Reliable detection and quantitation of viral nucleic acids in oral fluid: liquid phase-based sample collection in conjunction with automated and standardized molecular assays. J Med Virol 2008; 80: 1684-8.
99. Acikgoz G, Cengiz MI, Keskiner I, Acikgoz S, Can M, Acikgoz A. Correlation of hepatitis C antibody levels in gingival crevicular fluid and saliva of hepatitis C seropositive hemodialysis patients. Int J Dent 2009; 2009: 247121.
100. Shafique M, Ahmad N, Awan FR, Mustafa T, Ullah M, Qureshi JA. Investigating the concurrent presence of HCV in serum, oral fluid and urine samples from chronic HCV patients in Faisalabad, Pakistan. Arch Virol 2009; 154: 1523-7.
101. Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990; 336: 503-4.
102. Roy KM, Bagg J, McCarron B. The effect of saliva specimen collection, handling and storage protocols on hepatitis C virus (HCV) RNA detection by PCR. Oral Dis 1999; 5: 123-7.
103. O'Connell T, Thornton L, O'Flanagan D, et al. Prevalence of hepatitis B anti-core antibody in the Republic of Ireland. Epidemiol Infect 2000; 125: 701-4.
104. Quoilin S, Hutse V, Vandenberghe H, et al. A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium. Eur J Epidemiol 2007; 22: 195-202.
105. Uddin G, Shoeb D, Solaiman S, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat 2010; 17: 327-35.
106. Scheifele DW, De Serres G, Gilca V, et al. A nationwide survey of past hepatitis A infections among Canadian adults. Vaccine 2010; 28: 5174-8.
107. Madar R, Straka S, Baska T. Detection of antibodies in saliva--an effective auxiliary method in surveillance of infectious disease. Bratisl Lek Listy 2002; 103: 38-41.